The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development

Area of Science:

• Neuroimmunology
• Stroke Pathophysiology

Background:

• Stroke is a leading cause of death and disability, with current therapies having limitations.
• Infarcted brain tissue triggers inflammation, which is critical for repair but can also cause secondary damage.
• Stroke patients often experience immune suppression, increasing infection risk and worsening outcomes.

Purpose of the Study:

• To review the current understanding of the immune response following stroke.
• To explore the beneficial and detrimental roles of inflammation in stroke recovery.
• To identify potential therapeutic targets within the immune response pathway.

Main Methods:

• Review of existing literature on neuroinflammation and stroke.
• Analysis of the roles of various immune cells (microglia, macrophages, neutrophils) and endothelium.
• Discussion of systemic immune activation, immunodepression, and chronic immune responses.

Main Results:

• The immune response to stroke is biphasic, with both acute and chronic phases influencing recovery.
• Brain-resident and peripheral immune cells play critical roles in stroke pathophysiology.
• Systemic immune changes, including immunodepression, significantly impact patient outcomes.

Conclusions:

• A comprehensive understanding of the immune response's initiation, propagation, and termination is essential for novel therapeutic development.
• Targeting the immune response holds promise for improving outcomes in a broader stroke patient population.
• Balancing beneficial and detrimental inflammatory effects is crucial for effective stroke treatment.